Stem cells in the context of colon carcinogenesis (a literature review)

Authors

DOI:

https://doi.org/10.14739/2310-1210.2023.2.272160

Keywords:

stem cells, cancer stem cells, colon cancer, stem cell research

Abstract

Aim. To analyze the latest literature data on stem cells in general, intestinal stem cells in particular, as well as cancer stem cells in the context of colon carcinogenesis.

Over the past decade, a significant amount of data confirming the existence of cancer stem cells, their importance in cancer progression, resistance to current treatment regimens, and the occurrence of relapses has been accumulated. These cells are a small fraction of cancer cells that initiate tumor growth and provide tumor tissue heterogeneity. In addition, these cells are distinguished by a significant resistance to effects of various cytotoxic factors. Therefore, the possibility of isolating cancer stem cells and further targeted action are highly important for enabling a complete tumor eradication.

A study on intestinal stem cells has always been in the focus of stem cell biology researchers’ attention because intestinal stem cells are an example of an active cell population that provides regular rapid renewal of the epithelium, which is constantly exposed to toxic, bacterial, and other aggressive factors. Accordingly, colon carcinogenesis is a convenient model for studying the role of stem cells in tumorigenesis.

At the same time, there are two main current schemes of colon carcinogenesis, which are acknowledged – these are so-called “bottom-up” and “top-down” modes of transformed cell spreading. The “bottom-up” scheme was substantiated first, proving to be in good agreement with modern ideas about the structure of intestinal crypts. However, a little later, reports about the possibility of the “top-down” direction began to appear: differentiated cells located in the superficial parts of the intestinal crypts, undergoing mutations, could dedifferentiate and return to the basal parts; a pathological increase in the surface epithelial cells proliferation level was possible as well, leading to an increase in the luminal surface area, formation of grooves mimicking the intestinal crypts.

This review provides the latest data on stem cells in general, in particular on intestinal stem cells, as well as on cancer stem cells in the context of colon carcinogenesis. We also analyze the latest literature data on the possibility of isolating cancer stem cells in colon carcinomas using molecular markers, difficulties associated with this process, and issues that are still unresolved.

Conclusions. Today, there is no doubt about the existence and importance of cancer stem cells in carcinomas. Quite a lot of molecular markers of cancer stem cells have been identified and studied. It is worth noting that certain aspects of cancer stem cells can not be studied one-sidedly but require a multidimensional analysis.

Author Biography

M. A. Shyshkin, Zaporizhzhia State Medical University, Ukraine

MD, PhD, DSc, Associate Professor of the Department of Pathological Anatomy and Forensic Medicine

References

  1. Zakrzewski, W., Dobrzyński, M., Szymonowicz, M., & Rybak, Z. (2019). Stem cells: past, present, and future. Stem cell research & therapy, 10(1), 68. https://doi.org/10.1186/s13287-019-1165-5
  2. Rossi, F., Noren, H., Jove, R., Beljanski, V., & Grinnemo, K. H. (2020). Differences and similarities between cancer and somatic stem cells: therapeutic implications. Stem cell research & therapy, 11(1), 489. https://doi.org/10.1186/s13287-020-02018-6
  3. Batlle, E., & Clevers, H. (2017). Cancer stem cells revisited. Nature medicine, 23(10), 1124-1134. https://doi.org/10.1038/nm.4409
  4. Hatano, Y., Fukuda, S., Hisamatsu, K., Hirata, A., Hara, A., & Tomita, H. (2017). Multifaceted Interpretation of Colon Cancer Stem Cells. International journal of molecular sciences, 18(7), 1446. https://doi.org/10.3390/ijms18071446
  5. Barbato, L., Bocchetti, M., Di Biase, A., & Regad, T. (2019). Cancer Stem Cells and Targeting Strategies. Cells, 8(8), 926. https://doi.org/10.3390/cells8080926
  6. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine, 3(7), 730-737. https://doi.org/10.1038/nm0797-730
  7. Jahanafrooz, Z., Mosafer, J., Akbari, M., Hashemzaei, M., Mokhtarzadeh, A., & Baradaran, B. (2020). Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. Journal of cellular physiology, 235(5), 4153-4166. https://doi.org/10.1002/jcp.29337
  8. Taniguchi, H., Moriya, C., Igarashi, H., Saitoh, A., Yamamoto, H., Adachi, Y., & Imai, K. (2016). Cancer stem cells in human gastrointestinal cancer. Cancer science, 107(11), 1556-1562. https://doi.org/10.1111/cas.13069
  9. Oue, N., Sentani, K., Sakamoto, N., Uraoka, N., & Yasui, W. (2019). Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. International journal of clinical oncology, 24(7), 771-778. https://doi.org/10.1007/s10147-019-01443-9
  10. Heng, W. S., Gosens, R., & Kruyt, F. (2019). Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting. Biochemical pharmacology, 160, 121-133. https://doi.org/10.1016/j.bcp.2018.12.010
  11. Butti, R., Gunasekaran, V. P., Kumar, T., Banerjee, P., & Kundu, G. C. (2019). Breast cancer stem cells: Biology and therapeutic implications. The international journal of biochemistry & cell biology, 107, 38-52. https://doi.org/10.1016/j.biocel.2018.12.001
  12. Rycaj, K., & Tang, D. G. (2015). Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations. Cancer research, 75(19), 4003-4011. https://doi.org/10.1158/0008-5472.CAN-15-0798
  13. Nimmakayala, R. K., Batra, S. K., & Ponnusamy, M. P. (2019). Unraveling the journey of cancer stem cells from origin to metastasis. Biochimica et biophysica acta. Reviews on cancer, 1871(1), 50-63. https://doi.org/10.1016/j.bbcan.2018.10.006
  14. Gehart, H., & Clevers, H. (2019). Tales from the crypt: new insights into intestinal stem cells. Nature reviews. Gastroenterology & hepatology, 16(1), 19-34. https://doi.org/10.1038/s41575-018-0081-y
  15. Munro, M. J., Wickremesekera, S. K., Peng, L., Tan, S. T., & Itinteang, T. (2018). Cancer stem cells in colorectal cancer: a review. Journal of clinical pathology, 71(2), 110-116. https://doi.org/10.1136/jclinpath-2017-204739
  16. Cheng, H., & Leblond, C. P. (1974). Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. The American journal of anatomy, 141(4), 537-561. https://doi.org/10.1002/aja.1001410407
  17. Hong, Y., Liew, S. C., Thean, L. F., Tang, C. L., & Cheah, P. Y. (2018). Human colorectal cancer initiation is bidirectional, and cell growth, metabolic genes and transporter genes are early drivers of tumorigenesis. Cancer letters, 431, 213-218. https://doi.org/10.1016/j.canlet.2018.06.005
  18. Patel, A., Tripathi, G., Gopalakrishnan, K., Williams, N., & Arasaradnam, R. P. (2015). Field cancerisation in colorectal cancer: a new frontier or pastures past?. World journal of gastroenterology, 21(13), 3763-3772. https://doi.org/10.3748/wjg.v21.i13.3763
  19. Sphyris, N., Hodder, M. C., & Sansom, O. J. (2021). Subversion of Niche-Signalling Pathways in Colorectal Cancer: What Makes and Breaks the Intestinal Stem Cell. Cancers, 13(5), 1000. https://doi.org/10.3390/cancers13051000
  20. Angius, A., Scanu, A. M., Arru, C., Muroni, M. R., Rallo, V., Deiana, G., Ninniri, M. C., Carru, C., Porcu, A., Pira, G., Uva, P., Cossu-Rocca, P., & De Miglio, M. R. (2021). Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome. International journal of molecular sciences, 22(4), 1603. https://doi.org/10.3390/ijms22041603
  21. Alison, M. R. (2020). The cellular origins of cancer with particular reference to the gastrointestinal tract. International journal of experimental pathology, 101(5), 132-151. https://doi.org/10.1111/iep.12364
  22. Leung, C., Tan, S. H., & Barker, N. (2018). Recent Advances in Lgr5+ Stem Cell Research. Trends in cell biology, 28(5), 380-391. https://doi.org/10.1016/j.tcb.2018.01.010
  23. Drost, J., van Jaarsveld, R. H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A., Sachs, N., Overmeer, R. M., Offerhaus, G. J., Begthel, H., Korving, J., van de Wetering, M., Schwank, G., Logtenberg, M., Cuppen, E., Snippert, H. J., Medema, J. P., Kops, G. J., & Clevers, H. (2015). Sequential cancer mutations in cultured human intestinal stem cells. Nature, 521(7550), 43-47. https://doi.org/10.1038/nature14415
  24. Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Watanabe, T., Kanai, T., & Sato, T. (2015). Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Nature medicine, 21(3), 256-262. https://doi.org/10.1038/nm.3802
  25. Shimokawa, M., Ohta, Y., Nishikori, S., Matano, M., Takano, A., Fujii, M., Date, S., Sugimoto, S., Kanai, T., & Sato, T. (2017). Visualization and targeting of LGR5+ human colon cancer stem cells. Nature, 545(7653), 187-192. https://doi.org/10.1038/nature22081
  26. Fumagalli, A., Oost, K. C., Kester, L., Morgner, J., Bornes, L., Bruens, L., Spaargaren, L., Azkanaz, M., Schelfhorst, T., Beerling, E., Heinz, M. C., Postrach, D., Seinstra, D., Sieuwerts, A. M., Martens, J., van der Elst, S., van Baalen, M., Bhowmick, D., Vrisekoop, N., Ellenbroek, S., … van Rheenen, J. (2020). Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. Cell stem cell, 26(4), 569-578.e7. https://doi.org/10.1016/j.stem.2020.02.008
  27. De Sousa e Melo, F., Kurtova, A. V., Harnoss, J. M., Kljavin, N., Hoeck, J. D., Hung, J., Anderson, J. E., Storm, E. E., Modrusan, Z., Koeppen, H., Dijkgraaf, G. J., Piskol, R., & de Sauvage, F. J. (2017). A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer. Nature, 543(7647), 676-680. https://doi.org/10.1038/nature21713
  28. Chen, C., Zhao, S., Karnad, A., & Freeman, J. W. (2018). The biology and role of CD44 in cancer progression: therapeutic implications. Journal of hematology & oncology, 11(1), 64. https://doi.org/10.1186/s13045-018-0605-5
  29. Holah, N. S., Aiad, H. A., Asaad, N. Y., Elkhouly, E. A., & Lasheen, A. G. (2017). Evaluation of the role of CD44 as a cancer stem cell marker in colorectal carcinoma: immunohistochemical study. Menoufia Medical Journal, 30(1), 174. https://doi.org/10.4103/mmj.mmj_151_16
  30. Wang, L., Zuo, X., Xie, K., & Wei, D. (2018). The Role of CD44 and Cancer Stem Cells. Methods in molecular biology, 1692, 31-42. https://doi.org/10.1007/978-1-4939-7401-6_3
  31. Barzegar Behrooz, A., Syahir, A., & Ahmad, S. (2019). CD133: beyond a cancer stem cell biomarker. Journal of drug targeting, 27(3), 257-269. https://doi.org/10.1080/1061186X.2018.1479756
  32. Jang, J. W., Song, Y., Kim, S. H., Kim, J., & Seo, H. R. (2017). Potential mechanisms of CD133 in cancer stem cells. Life sciences, 184, 25-29. https://doi.org/10.1016/j.lfs.2017.07.008
  33. Liou, G. Y. (2019). CD133 as a regulator of cancer metastasis through the cancer stem cells. The international journal of biochemistry & cell biology, 106, 1-7. https://doi.org/10.1016/j.biocel.2018.10.013
  34. Prabavathy, D., & Ramadoss, N. (2019). Heterogeneity of Small Cell Lung Cancer Stem Cells. Advances in experimental medicine and biology, 1139, 41-57. https://doi.org/10.1007/978-3-030-14366-4_3
  35. Liu, C. L., Chen, Y. J., Fan, M. H., Liao, Y. J., & Mao, T. L. (2020). Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma. International journal of molecular sciences, 21(18), 6467. https://doi.org/10.3390/ijms21186467
  36. Altevogt, P., Sammar, M., Hüser, L., & Kristiansen, G. (2021). Novel insights into the function of CD24: A driving force in cancer. International journal of cancer, 148(3), 546-559. https://doi.org/10.1002/ijc.33249
  37. Li, W., Ma, H., Zhang, J., Zhu, L., Wang, C., & Yang, Y. (2017). Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Scientific reports, 7(1), 13856. https://doi.org/10.1038/s41598-017-14364-2
  38. Tarhriz, V., Bandehpour, M., Dastmalchi, S., Ouladsahebmadarek, E., Zarredar, H., & Eyvazi, S. (2019). Overview of CD24 as a new molecular marker in ovarian cancer. Journal of cellular physiology, 234(3), 2134-2142. https://doi.org/10.1002/jcp.27581
  39. Ishiwata, T., Matsuda, Y., Yoshimura, H., Sasaki, N., Ishiwata, S., Ishikawa, N., Takubo, K., Arai, T., & Aida, J. (2018). Pancreatic cancer stem cells: features and detection methods. Pathology oncology research : POR, 24(4), 797-805. https://doi.org/10.1007/s12253-018-0420-x
  40. Enz, N., Vliegen, G., De Meester, I., & Jungraithmayr, W. (2019). CD26/DPP4 - a potential biomarker and target for cancer therapy. Pharmacology & therapeutics, 198, 135-159. https://doi.org/10.1016/j.pharmthera.2019.02.015
  41. Lefort, É. C., Diaconu, B., Bentley, V. L., & Blay, J. (2020). Apigenin upregulation of CD26/DPPIV on colon epithelial cells requires inhibition of casein kinase 2. Food science & nutrition, 8(10), 5321-5329. https://doi.org/10.1002/fsn3.1823
  42. Beckenkamp, A., Davies, S., Willig, J. B., & Buffon, A. (2016). DPPIV/CD26: a tumor suppressor or a marker of malignancy?. Tumour biology, 37(6), 7059-7073. https://doi.org/10.1007/s13277-016-5005-2
  43. Hamidi, H., Pietilä, M., & Ivaska, J. (2016). The complexity of integrins in cancer and new scopes for therapeutic targeting. British journal of cancer, 115(9), 1017-1023. https://doi.org/10.1038/bjc.2016.312
  44. Hamidi, H., & Ivaska, J. (2018). Every step of the way: integrins in cancer progression and metastasis. Nature reviews. Cancer, 18(9), 533-548. https://doi.org/10.1038/s41568-018-0038-z
  45. Brinkhof, B., Zhang, B., Cui, Z., Ye, H., & Wang, H. (2020). ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation. Gene: X, 5, 100031. https://doi.org/10.1016/j.gene.2020.100031
  46. Han, S., Yang, W., Zong, S., Li, H., Liu, S., Li, W., Shi, Q., & Hou, F. (2017). Clinicopathological, prognostic and predictive value of CD166 expression in colorectal cancer: a meta-analysis. Oncotarget, 8(38), 64373-64384. https://doi.org/10.18632/oncotarget.17442
  47. Keller, L., Werner, S., & Pantel, K. (2019). Biology and clinical relevance of EpCAM. Cell stress, 3(6), 165-180. https://doi.org/10.15698/cst2019.06.188
  48. Boesch, M., Spizzo, G., & Seeber, A. (2018). Concise Review: Aggressive Colorectal Cancer: Role of Epithelial Cell Adhesion Molecule in Cancer Stem Cells and Epithelial-to-Mesenchymal Transition. Stem cells translational medicine, 7(6), 495-501. https://doi.org/10.1002/sctm.17-0289
  49. Chai, X. B., Song, R. F., & Xu, F. (2015). Expression changes in epithelial cell adhesion molecule during colorectal cancer tumorigenesis. Genetics and molecular research : GMR, 14(3), 7624-7629. https://doi.org/10.4238/2015.July.13.6
  50. Han, S., Zong, S., Shi, Q., Li, H., Liu, S., Yang, W., Li, W., & Hou, F. (2017). Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis. EBioMedicine, 20, 61-69. https://doi.org/10.1016/j.ebiom.2017.05.025
  51. Huth, C., Kloor, M., Voigt, A. Y., Bozukova, G., Evers, C., Gaspar, H., Tariverdian, M., Schirmacher, P., von Knebel Doeberitz, M., & Bläker, H. (2012). The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. Modern pathology, Inc, 25(6), 911-916. https://doi.org/10.1038/modpathol.2012.30
  52. Murakami, N., Mori, T., Nakamura, S., Yoshimoto, S., Honma, Y., Ueno, T., Kobayashi, K., Kashihara, T., Takahashi, K., Inaba, K., Okuma, K., Igaki, H., Nakayama, Y., & Itami, J. (2019). Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy. Journal of radiation research, 60(6), 803-811. https://doi.org/10.1093/jrr/rrz053
  53. Dai, M., Yuan, F., Fu, C., Shen, G., Hu, S., & Shen, G. (2017). Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. PloS one, 12(4), e0175357. https://doi.org/10.1371/journal.pone.0175357
  54. Gzil, A., Zarębska, I., Bursiewicz, W., Antosik, P., Grzanka, D., & Szylberg, Ł. (2019). Markers of pancreatic cancer stem cells and their clinical and therapeutic implications. Molecular biology reports, 46(6), 6629-6645. https://doi.org/10.1007/s11033-019-05058-1
  55. Vassalli, G. (2019). Aldehyde Dehydrogenases: Not Just Markers, but Functional Regulators of Stem Cells. Stem cells international, 2019, 3904645. https://doi.org/10.1155/2019/3904645
  56. Chen, J., Xia, Q., Jiang, B., Chang, W., Yuan, W., Ma, Z., Liu, Z., & Shu, X. (2015). Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. PloS one, 10(12), e0145164. https://doi.org/10.1371/journal.pone.0145164
  57. Singh, S., Arcaroli, J., Thompson, D. C., Messersmith, W., & Vasiliou, V. (2015). Acetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancers. Advances in experimental medicine and biology, 815, 281-294. https://doi.org/10.1007/978-3-319-09614-8_16
  58. Mahmood, N. A., Abdulghany, Z. S., & Al-Sudani, I. M. (2018). Expression of Aldehyde Dehydrogenase (ALDH1) and ATP Binding Cassette Transporter G2 (ABCG2) in Iraqi Patients with Colon Cancer and the Relation with Clinicopathological Features. International journal of molecular and cellular medicine, 7(4), 234-240. https://doi.org/10.22088/IJMCM.BUMS.7.4.234

Downloads

Published

2023-03-28

How to Cite

1.
Shyshkin MA. Stem cells in the context of colon carcinogenesis (a literature review). Zaporozhye Medical Journal [Internet]. 2023Mar.28 [cited 2026May13];25(2):164-71. Available from: https://zmj.zsmu.edu.ua/article/view/272160

Issue

Vol. 25 No. 2 (2023)

Section

Review

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons